Trial result ·
Combination therapy with furosemide and metolazone as compared to furosemide alone for treatment of edema in children with nephrotic syndrome: a randomized controlled trial.
Written based on 1 research study on PubMed, searched on 15 Nov 2026.
What was studied
Children with nephrotic syndrome often have swelling from fluid, called edema. This trial asked if adding metolazone to furosemide helps clear the fluid. Kids aged 1-14 years with moderate to severe swelling took part. By chance, 25 got both drugs and 25 got furosemide alone. The team tracked urine and weight over 48 hours.
What they found
Urine output over 48 hours did not clearly differ between the groups. At first, the rise in urine from the start looked bigger with both drugs. Once starting urine was taken into account, this gap was not statistically clear. Weight loss, blood salt levels and hospital stay were similar in the groups. Some kids on both drugs lost so much weight their drugs had to stop.
What it means for patients
The authors saw no gain in urine or weight loss from adding metolazone. Some children also had to stop the drug pair early. So the authors say these results do not back giving both drugs from the start. They see the findings as ideas to test in chosen groups of children.
Why it is not certain yet
The trial had 25 children in each group. Kids were followed for just 48 hours. One result was only clear before start levels were taken into account. The abstract gives no results after the hospital stay. The authors say more studies are needed in chosen groups.
Source
Combination therapy with furosemide and metolazone as compared to furosemide alone for treatment of edema in children with nephrotic syndrome: a randomized controlled trial.
PubMed · PMID 42801339We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Nephrotic syndrome publications